Source: Antidote Blog

Antidote Blog Planning for Patient Recruitment in 2025: Strategies to Stay Ahead of the Curve

Looking toward 2025, clinical trial sponsors must plan now and rethink their patient recruitment strategies to stay ahead of evolving technologies, regulations, and shifting patient expectations. The landscape of clinical trials is changing rapidly, and recruitment will require a more agile, data-driven, and patient-centric approach than ever before. While patient recruitment has always posed challenges, the next few years will demand innovative solutions to improve efficiency, enhance patient engagement, and meet increasing diversity goals. Sponsors who take proactive steps today will be better positioned to run successful trials and build stronger relationships with patients.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Laurent Schockmel's photo - CEO of Antidote

CEO

Laurent Schockmel

CEO Approval Rating

92/100

Read more